Atrial septal defect video showing percutaneous occluder devices: Difference between revisions
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...) |
|||
| (6 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Atrial septal defect}} | {{Atrial septal defect}} | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto: | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]; {{CZ}} '''Assistant Editor(s)-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@elon.edu] | ||
==Overview== | ==Overview== | ||
The Amplatzer septal occluder (ASO) is currently the most widely used device because it is easy to implant and has high success rates. It first came to be used for human subjects in 1995. However, the device is still not approved for usage in percutaneous closure of [[Atrial septal defect ostium primum|primum]], [[Atrial septal defect sinus venosus|sinus venosus]] and [[Atrial septal defect coronary sinus | coronary sinus]] type of [[atrial septal defect]]s. The [[Food and Drug Administration]] has authorized the following percutaenous transcatheters for usage:<ref name="pmid11829678">{{cite journal| author=Schwetz BA| title=From the Food and Drug Administration. | journal=JAMA | year= 2002 | volume= 287 | issue= 5 | pages= 578 | pmid=11829678 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11829678 }} </ref>. | The Amplatzer septal occluder (ASO) is currently the most widely used device because it is easy to implant and has high success rates. It first came to be used for human subjects in 1995. However, the device is still not approved for usage in percutaneous closure of [[Atrial septal defect ostium primum|primum]], [[Atrial septal defect sinus venosus|sinus venosus]] and [[Atrial septal defect coronary sinus | coronary sinus]] type of [[atrial septal defect]]s. | ||
==Type of occluders== | |||
The [[Ampltazer septal occluder]] (ASO) is the most commonly used device as it allows closure of large cavities, is easy to implant, and boasts high success rates. As an instrument, the [[Ampltazer septal occluder]] consists of two self-expandable round discs connected to each other with a 4-mm waist, made up of 0.004–0.005´´ nitinol wire mesh filled with Dacron fabric. The prevalence of residual defect is low. The [[Food and Drug Administration]] has authorized the following percutaenous transcatheters for usage:<ref name="pmid11829678">{{cite journal| author=Schwetz BA| title=From the Food and Drug Administration. | journal=JAMA | year= 2002 | volume= 287 | issue= 5 | pages= 578 | pmid=11829678 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11829678 }} </ref>. | |||
*Amplatzer septal occluder | *Amplatzer septal occluder | ||
| Line 10: | Line 14: | ||
*Sideris patch | *Sideris patch | ||
{{#ev:youtube|4c3CEgjj2PY}} | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 00:54, 2 November 2012
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect video showing percutaneous occluder devices On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect video showing percutaneous occluder devices | |
|
FDA on Atrial septal defect video showing percutaneous occluder devices | |
|
CDC on Atrial septal defect video showing percutaneous occluder devices | |
|
Atrial septal defect video showing percutaneous occluder devices in the news | |
|
Blogs on Atrial septal defect video showing percutaneous occluder devices | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
The Amplatzer septal occluder (ASO) is currently the most widely used device because it is easy to implant and has high success rates. It first came to be used for human subjects in 1995. However, the device is still not approved for usage in percutaneous closure of primum, sinus venosus and coronary sinus type of atrial septal defects.
Type of occluders
The Ampltazer septal occluder (ASO) is the most commonly used device as it allows closure of large cavities, is easy to implant, and boasts high success rates. As an instrument, the Ampltazer septal occluder consists of two self-expandable round discs connected to each other with a 4-mm waist, made up of 0.004–0.005´´ nitinol wire mesh filled with Dacron fabric. The prevalence of residual defect is low. The Food and Drug Administration has authorized the following percutaenous transcatheters for usage:[1].
- Amplatzer septal occluder
- CardioSEAL
- HELEX septal occluder
- Sideris patch
{{#ev:youtube|4c3CEgjj2PY}}
References
- ↑ Schwetz BA (2002). "From the Food and Drug Administration". JAMA. 287 (5): 578. PMID 11829678.